LSV Asset Management Has $9.50 Million Stake in Globe Life Inc. $GL

LSV Asset Management grew its stake in shares of Globe Life Inc. (NYSE:GL) by 16.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 66,415 shares of the company’s stock after buying an additional 9,335 shares during the period. LSV Asset Management owned approximately 0.08% of Globe Life worth $9,495,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Mather Group LLC. acquired a new stake in shares of Globe Life in the 3rd quarter valued at approximately $28,000. CYBER HORNET ETFs LLC bought a new stake in Globe Life in the second quarter valued at approximately $28,000. Assetmark Inc. raised its holdings in Globe Life by 777.8% in the second quarter. Assetmark Inc. now owns 237 shares of the company’s stock worth $29,000 after purchasing an additional 210 shares during the period. MUFG Securities EMEA plc bought a new position in shares of Globe Life during the second quarter worth $31,000. Finally, Quent Capital LLC acquired a new position in shares of Globe Life in the 3rd quarter valued at $36,000. 81.61% of the stock is owned by institutional investors.

Globe Life Stock Up 0.2%

GL stock opened at $144.46 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.07 and a quick ratio of 0.07. The stock has a market capitalization of $11.50 billion, a P/E ratio of 10.26 and a beta of 0.47. Globe Life Inc. has a fifty-two week low of $109.38 and a fifty-two week high of $152.71. The business has a 50-day moving average of $140.57 and a 200-day moving average of $138.41.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The firm had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the prior year, the business posted $3.14 EPS. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, sell-side analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Insider Buying and Selling at Globe Life

In related news, EVP Michael Clay Majors sold 30,000 shares of the firm’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $146.89, for a total value of $4,406,700.00. Following the completion of the transaction, the executive vice president owned 47,066 shares of the company’s stock, valued at approximately $6,913,524.74. This trade represents a 38.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Mark A. Blinn sold 1,750 shares of Globe Life stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $147.91, for a total value of $258,842.50. Following the completion of the sale, the director directly owned 3,372 shares in the company, valued at approximately $498,752.52. This represents a 34.17% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 51,129 shares of company stock worth $7,414,035. Company insiders own 1.51% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. TD Cowen reaffirmed a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Piper Sandler restated an “overweight” rating and issued a $167.00 price target on shares of Globe Life in a report on Friday, November 21st. Weiss Ratings upgraded Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday. JPMorgan Chase & Co. boosted their price objective on Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Finally, Morgan Stanley restated an “overweight” rating and set a $176.00 target price on shares of Globe Life in a report on Monday, December 15th. Eight investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $171.00.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.